These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Autoimmune hepatitis in human immunodeficiency virus-infected patients: A case series and review of the literature. Chaiteerakij R; Sanpawat A; Avihingsanon A; Treeprasertsuk S World J Gastroenterol; 2019 Sep; 25(35):5388-5402. PubMed ID: 31558881 [TBL] [Abstract][Full Text] [Related]
43. Hepatic stellate cell activation and hepatic fibrosis in children with type 1 autoimmune hepatitis: an immunohistochemical study of paired liver biopsies before treatment and after clinical remission. Maia JM; Maranhão Hde S; Sena LV; Rocha LR; Medeiros IA; Ramos AM Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):264-9. PubMed ID: 20009940 [TBL] [Abstract][Full Text] [Related]
50. Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis. Wang Q; Selmi C; Zhou X; Qiu D; Li Z; Miao Q; Chen X; Wang J; Krawitt EL; Gershwin ME; Han Y; Ma X J Autoimmun; 2013 Mar; 41():140-5. PubMed ID: 23187010 [TBL] [Abstract][Full Text] [Related]
51. Acute Exacerbation to Autoimmune Hepatitis Mimicking Acute Viral Hepatitis-A Case Series and Review of Literature. Taneja S; Kumar P; Mitra S; Duseja A; Minz R; Das A; Dhiman RK; Chawla Y J Clin Exp Hepatol; 2018 Mar; 8(1):98-103. PubMed ID: 29743801 [TBL] [Abstract][Full Text] [Related]
52. Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy. Inductivo-Yu I; Adams A; Gish RG; Wakil A; Bzowej NH; Frederick RT; Bonacini M Clin Gastroenterol Hepatol; 2007 Jul; 5(7):799-802. PubMed ID: 17509945 [TBL] [Abstract][Full Text] [Related]
54. Impact of immunosuppressive treatment on liver fibrosis in autoimmune hepatitis. Mohamadnejad M; Malekzadeh R; Nasseri-Moghaddam S; Hagh-Azali S; Rakhshani N; Tavangar SM; Sedaghat M; Alimohamadi SM Dig Dis Sci; 2005 Mar; 50(3):547-51. PubMed ID: 15810640 [TBL] [Abstract][Full Text] [Related]
55. Clinical characteristics of paediatric autoimmune hepatitis at a referral hospital in Sub Saharan Africa. Afaa TJ; Amegan-Aho KH; Dono MT; Odei E; Awuku YA PLoS One; 2020; 15(12):e0239964. PubMed ID: 33362271 [TBL] [Abstract][Full Text] [Related]
56. Outcomes in Pediatric Autoimmune Hepatitis and Significance of Azathioprine Metabolites. Sheiko MA; Sundaram SS; Capocelli KE; Pan Z; McCoy AM; Mack CL J Pediatr Gastroenterol Nutr; 2017 Jul; 65(1):80-85. PubMed ID: 28272159 [TBL] [Abstract][Full Text] [Related]
57. Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents. Woynarowski M; Nemeth A; Baruch Y; Koletzko S; Melter M; Rodeck B; Strassburg CP; Pröls M; Woźniak M; Manns MP; J Pediatr; 2013 Nov; 163(5):1347-53.e1. PubMed ID: 23810723 [TBL] [Abstract][Full Text] [Related]
58. Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort study. Ludz C; Stirnimann G; Semela D; Mertens J; Kremer AE; Filipowicz Sinnreich M; Sokollik C; Bernsmeier C; Bresson-Hadni S; McLin V; Rock N; Braegger C; Posovszky C; Müller P; Cremer M; De Gottardi A; Galante A; Furlano R; Righini-Grunder F; Becker B; Böhm S; Heyland K; Nydegger A; Limoni C; Vergani D; Mieli-Vergani G; Di Bartolomeo C; Cerny A; Terziroli Beretta-Piccoli B Swiss Med Wkly; 2023 Aug; 153():40102. PubMed ID: 37769636 [TBL] [Abstract][Full Text] [Related]